Jake Bauer
CIK 1654909 · Chief Business Officer · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.78M
Companies
4
Total Filings
45
Lifetime Open-Market Net
-$6.56M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBOT | Director | — | $8.59 | — | $0 | 2 | 2026-06-18 |
| IMVT | Director | 38,896 | $38.90 | $1.51M | $0 | 2 | 2026-04-09 |
| IMRA | Director | 87,372 | $14.49 | $1.27M | $0 | 6 | 2026-02-17 |
| MyoKardia, Inc. (MYOK) Delisted | Chief Business Officer | 57,784 | — | — | -$6.56M | 34 | 2020-06-04 |
Recent Filings · Page 2 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-19 | — | Mixed | −90,209 | $0 | |
| 2020-06-04 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | +293 | $14.8K | EDGAR |
| 2020-02-19 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-07 | MyoKardia, Inc. (MYOK) Delisted | Mixed | +7,534 | -$153.7K | EDGAR |
| 2020-01-03 | MyoKardia, Inc. (MYOK) Delisted | Exer (M) | +6,375 | $0 | EDGAR |
| 2019-12-23 | MyoKardia, Inc. (MYOK) Delisted | Mixed | −1,416 | -$1.13M | EDGAR |
| 2019-12-02 | MyoKardia, Inc. (MYOK) Delisted | Sell (S) | −21,232 | -$1.39M | EDGAR |
| 2019-11-08 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | +162 | $6.5K | EDGAR |
| 2019-09-24 | MyoKardia, Inc. (MYOK) Delisted | Mixed | — | -$974.2K | EDGAR |
| 2019-06-03 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | +313 | $12.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.